Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin

Transplantation

Volumn 61, Issue 8, 1996, Pages 1228-1233

  Fu, Fumin ^a   Thai, Ngoc L ^a   Li, Youping ^a   Lu, Lina ^a   Thomson, Angus W ^a   Fung, John J ^a   Qian, Shiguang ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SKIN GRAFT; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL LINEAGE; GRAFT REJECTION; LIVER; LIVER TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H;

EID: 0029926004     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00019     Document Type: Article

References (25)

1. Chapman JR. The sensitized patient. In: Thomson AW, Catto GRD, eds. Immunology of renal transplantation. Boston: Little, Brown, 1993: 235.
2. Thompson JS, Bryne JE, Hempel HO, et al. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigen in highly sensitized patients. Transplant Proc 1993; 25: 251.
3. McKenzie JL, Beard MEJ, Hart DNJ. The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation 1984; 38: 371.
4. Kahn DR, Forrest DE, Otto DA. Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate: enhancement by combined immunosuppressant treatment of the recipients. Transplantation 1991; 52: 697.
5. Stegall MD, Tezuka K, Oluwole SF, et al. Interstitial class II-positive cell deletion by donor pretreatment with gamma irradiation: evidence of differential immunogenicity between vascularized cardiac allografts and islets. Transplantation 1990; 49: 246.
6. Young E, Olkowski ST, Dana M, Mallette RA, Stark WJ. Pretreatment of donor corneal endothelium with ultraviolet-B irradiation. Transplant Proc 1989; 21: 3145.
7. Williams JG, Pirenne J, Mayoral JM, et al. Effect of donor pre-treatment with anti-lymphocyte globulin on small bowel transplantation in rats. Br J Surg 1991; 78: 1176.
8. Faustman D, Steinman RM, Gebel H, Hauptfeld V, Davis J, Lacy P. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci USA 1984; 81: 3864.
9. Brewer Y, Palmer A, Taube DH, et al. Effect of graft perfusion with two CD45 monoclonal antibodies on the incidence of kidney allograft rejection. Lancet 1989; 334: 935.
10. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
11. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature (London) 1953; 172: 603.
12. Qian S, Fung JJ, Demetris AJ, Ildstad ST, Starzl TE. Orthotopic liver transplantation in the mouse. Transplantation 1991; 52: 562.
13. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
14. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented Th1 function. Transplantation 1995; 59: 274.
15. Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR protocols: a guide to methods and applications 1990. San Diego, CA: Academic.
16. Wang SC, Ford HR, Thai NI, et al. Correlation of lymphokine protein and mRNA levels in sponge matrix allografts. Transplantation (in press).
17. Qian S, Fung JJ, Sun H, Demetris AJ, Starzl TE. Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc 1992; 24: 1605.
18. Thai NL, Qian S, Fu F, et al. Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc 1995; 27: 509.
19. Sriwatanawongsa V, Davies HffS, Brons IGM, White DJG, Jamieson NV, Calne RY. Conditions required for donor passenger leukocytes in the induction of tolerance by rat liver grafts. Transplant Proc 1993; 25: 2855.
20. Hancock WW, Di Stefano R, Braun P, Schweizer R, Tilney NL, Kupiec-Weglinski JW. CsA and anti-interleukin 2-receptor monoclonal antibody therapy in rats suppress accelerated rejection of cardiac allografts through different effector mechanisms. Transplantation 1990; 48: 416.
21. Schmidbauer G, Hancock WW, Wasowska BA, Sablinski T, Kupiec-Weglinski JW. Rapamycin treatment prevents and/or erazes sensitization and abrogates accelerated rejection of vascularized organ allografts. Transplant Proc 1993; 25: 712.
22. + cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 1991; 51: 226.
23. Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats. Transplantation 1994; 58: 80.
24. Frantz FW, Terris DJ, Wyble CW, et al. Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation. Transplant Proc 1988; 20: 193.
25. Qian S, Fu F, Li Y, et al. Presensitization by skin grafting from MHC class I or MHC class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology 1995; 85: 82.